Thursday, September 19, 2024
- Advertisement -spot_img

TAG

Medicare

Novo says Ozempic ‘very likely’ to be on 2027 Medicare negotiation list, Bloomberg News reports

(Reuters) - Danish drugmaker Novo Nordisk expects its diabetes drug Ozempic will "very likely" be on the U.S. government's 2027 list of price negotiations,...

Latest news

- Advertisement -spot_img